Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort (Q45812853)

16 December 2017

title

Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort (English)

1 reference

16 December 2017

systemic lupus erythematosus

main subject

0 references

author name string

Louise Watson

1

1 reference

16 December 2017

Valentina Leone

2

1 reference

16 December 2017

Clarissa Pilkington

3

1 reference

16 December 2017

Kjell Tullus

4

1 reference

16 December 2017

Satyapal Rangaraj

5

1 reference

16 December 2017

Janet E McDonagh

6

1 reference

16 December 2017

Janet Gardner-Medwin

7

1 reference

16 December 2017

Nick Wilkinson

8

1 reference

16 December 2017

Phil Riley

9

1 reference

16 December 2017

Jane Tizard

10

1 reference

16 December 2017

Kate Armon

11

1 reference

16 December 2017

Manish D Sinha

12

1 reference

16 December 2017

Yiannis Ioannou

13

1 reference

16 December 2017

Neil Archer

14

1 reference

16 December 2017

Kathryn Bailey

15

1 reference

16 December 2017

Joyce Davidson

16

1 reference

16 December 2017

Eileen M Baildam

17

1 reference

16 December 2017

Gavin Cleary

18

1 reference

16 December 2017

Liza J McCann

19

1 reference

16 December 2017

Michael W Beresford

20

1 reference

16 December 2017

UK Juvenile-Onset Systemic Lupus Erythematosus Study Group

21

1 reference

16 December 2017

publication date

1 July 2012

1 reference

16 December 2017

published in

Arthritis & Rheumatology

1 reference

16 December 2017

volume

64

1 reference

16 December 2017

issue

7

1 reference

16 December 2017

page(s)

2356-2365

1 reference

16 December 2017

Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII)

cites work

1 reference

Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins

21 January 2018

1 reference

Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients

21 January 2018

1 reference

Childhood-onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus

21 January 2018

1 reference

Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades

21 January 2018

1 reference

The 1982 revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

Childhood- and adult-onset lupus: an update of similarities and differences.

21 January 2018

1 reference

Pediatric lupus--are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus?

21 January 2018

1 reference

The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents

21 January 2018

1 reference

The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus

21 January 2018

1 reference

Numerical scoring for the BILAG-2004 index

21 January 2018

1 reference

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

21 January 2018

1 reference

Severe clinical course of systemic lupus erythematosus in the first year of life

21 January 2018

1 reference

Distinctive clinical features of pediatric systemic lupus erythematosus in three different age classes

21 January 2018

1 reference

Renal outcomes in children with lupus and a family history of autoimmune disease.

21 January 2018

1 reference

Early disease onset is predicted by a higher genetic risk for lupus and is associated with a more severe phenotype in lupus patients

21 January 2018

1 reference

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

21 January 2018

1 reference

Adolescent development and SLE.

21 January 2018

1 reference

Making the diagnosis of systemic lupus erythematosus in children and adolescents

21 January 2018

1 reference

Assessment of a lupus nephritis cohort over a 30-year period.

21 January 2018

1 reference

Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome

21 January 2018

1 reference

Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices

21 January 2018

1 reference

British Isles Lupus Assessment Group 2004 index is valid for assessment of disease activity in systemic lupus erythematosus

21 January 2018

1 reference

Cyclophosphamide and cancer: golden anniversary

21 January 2018

1 reference

Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry

21 January 2018

1 reference

Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide

21 January 2018

1 reference

The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide

21 January 2018

1 reference

Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ART.34410

1 reference

16 December 2017

PubMed ID

22294381

1 reference

16 December 2017